Pfizer Inc is an American multinational pharmaceutical company. After extensive medical and marketing research, Pfizer believes it can penetrate the antiviral drugs market. It is considering two alternative products. The first is an emergency medication for coronavirus (COVID-19) for people ages 12 and older. The second is a pharmacy medicine for the same virus but for patients ages 18 and older. Both products would be introduced at a price of £8.75 per package in real terms. The emergency medication is projected to sell 2 million packages a year, whereas the pharmacy medicines would sell 4.0 million packages a year. Cash costs of production in the first year are expected to be £4.65 per package in real terms for the emergency medication. Production costs are expected to be £5.20 in real terms for pharmacy medicines. All prices and costs are expected to rise at the general inflation rate of 2 percent. Either product requires further investment. The emergency medication could be produced using equipment costing £18 million. That equipment would last three years and have no resale value. The machinery required to produce the pharmacy medicines would cost £31 million and last three years. The firm expects that equipment to have a £1,000,000 resale value (in real terms) at the end of Year 3. The firm uses straight-line depreciation and has a tax rate of 21 percent. The appropriate real discount rate is 8 percent. Required: Pfizer has hired you as a consultant to evaluate the investment options. Advice Pfizer the best option(s) with clear explanations. You should specify any additional assumptions you make in your analysis. Word Limit: maximum 3 pages, excluding references.
Pfizer Inc is an American multinational pharmaceutical company. After extensive medical and marketing research, Pfizer believes it can penetrate the antiviral drugs market. It is considering two alternative products. The first is an emergency medication for coronavirus (COVID-19) for people ages 12 and older. The second is a pharmacy medicine for the same virus but for patients ages 18 and older. Both products would be introduced at a price of £8.75 per package in real terms. The emergency medication is projected to sell 2 million packages a year, whereas the pharmacy medicines would sell 4.0 million packages a year. Cash costs of production in the first year are expected to be £4.65 per package in real terms for the emergency medication. Production costs are expected to be £5.20 in real terms for pharmacy medicines. All prices and costs are expected to rise at the general inflation rate of 2 percent. Either product requires further investment. The emergency medication could be produced using equipment costing £18 million. That equipment would last three years and have no resale value. The machinery required to produce the pharmacy medicines would cost £31 million and last three years. The firm expects that equipment to have a £1,000,000 resale value (in real terms) at the end of Year 3. The firm uses straight-line depreciation and has a tax rate of 21 percent. The appropriate real discount rate is 8 percent. Required: Pfizer has hired you as a consultant to evaluate the investment options. Advice Pfizer the best option(s) with clear explanations. You should specify any additional assumptions you make in your analysis. Word Limit: maximum 3 pages, excluding references.
Business/Professional Ethics Directors/Executives/Acct
8th Edition
ISBN:9781337485913
Author:BROOKS
Publisher:BROOKS
Chapter5: Corporate Ethical Governance & Accountabililty
Section: Chapter Questions
Problem 3.1EC
Related questions
Question
Transcribed Image Text:Pfizer Inc is an American multinational pharmaceutical company. After extensive medical and marketing
research, Pfizer believes it can penetrate the antiviral drugs market. It is considering two alternative products.
The first is an emergency medication for coronavirus (COVID-19) for people ages 12 and older. The second is
a pharmacy medicine for the same virus but for patients ages 18 and older. Both products would be introduced
at a price of £8.75 per package in real terms. The emergency medication is projected to sell 2 million packages
a year, whereas the pharmacy medicines would sell 4.0 million packages a year. Cash costs of production in the
first year are expected to be £4.65 per package in real terms for the emergency medication. Production costs are
expected to be £5.20 in real terms for pharmacy medicines. All prices and costs are expected to rise at the
general inflation rate of 2 percent.
Either product requires further investment. The emergency medication could be produced using equipment
costing £18 million. That equipment would last three years and have no resale value. The machinery required to
produce the pharmacy medicines would cost £31 million and last three years. The firm expects that equipment
to have a £1,000,000 resale value (in real terms) at the end of Year 3.
The firm uses straight-line depreciation and has a tax rate of 21 percent. The appropriate real discount rate is 8
percent.
Required:
Pfizer has hired you as a consultant to evaluate the investment options. Advice Pfizer the best option(s) with
clear explanations. You should specify any additional assumptions you make in your analysis.
Word Limit: maximum 3 pages, excluding references.
Expert Solution
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
Step by step
Solved in 6 steps
Follow-up Questions
Read through expert solutions to related follow-up questions below.
Recommended textbooks for you
Business/Professional Ethics Directors/Executives…
Accounting
ISBN:
9781337485913
Author:
BROOKS
Publisher:
Cengage
Business/Professional Ethics Directors/Executives…
Accounting
ISBN:
9781337485913
Author:
BROOKS
Publisher:
Cengage